Diodos, Ruel P.

HRN: 17-42-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/05/2022
CEFTRIAXONE 1G (VIAL)
11/05/2022
11/11/2022
IV
2g
OD
CAP MR
Waiting Final Action 
11/05/2022
AZITHROMYCIN 500MG TABLET (TAB)
11/05/2022
11/09/2022
IV
500mg
OD
Cap Mr
Waiting Final Action 
11/05/2022
CEFTAZIDIME 1GM (VIAL)
11/05/2022
11/11/2022
IVT
1g
Q8
CAP-HR, T/C PTB Relapse
Waiting Final Action 
11/06/2022
CEFTAZIDIME 1GM (VIAL)
11/06/2022
11/12/2022
IVT
2g
Q8
Sepsis, CAP-HR, T/C PTB Relapse (increased Dose)
Waiting Final Action 
11/06/2022
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
11/06/2022
11/12/2022
IVT
750mg
OD
Sepsis, CAP-HR, T/C PTB Relapse
Waiting Final Action 
11/08/2022
CEFTAZIDIME 1GM (VIAL)
11/08/2022
11/14/2022
IV
2g
Q8h
CAP HR
Waiting Final Action 
11/12/2022
CEFIXIME 200MG (CAP)
11/13/2022
11/19/2022
ORAL
200mg
BID
Cap HR; PTB
Waiting Final Action 
11/19/2022
MUPIROCIN 2%, 15G (TUBE)
11/19/2022
11/25/2022
TOPICAL
1 Squirt
BID
Bed Sores
Waiting Final Action 
11/23/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
11/23/2022
11/29/2022
IV
600mg
Q8
Aspiration Pneumonia
Waiting Final Action 
11/24/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
11/24/2022
12/01/2022
IV
1.5gms
Q6
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: